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Abstract Chylous ascites occurring after abdominal sur-
gery is rare. Despite being potentially critical, there is no
deﬁnite treatment guideline because of its rarity. Here we
present a case of massive chylous ascites occurring after
rectal surgery which was successfully treated with an oral
fat-free elemental diet (ED). A 67-year-old man underwent
low anterior resection with para-aortic lymphadenectomy
for advanced rectal cancer. Early postoperative course was
uneventful and the patient was discharged from hospital
10 days after surgery; however, after discharge, abdomi-
nal distension rapidly developed. Abdominal computed
tomography (CT) performed 3 weeks after surgery revealed
massive ascites and laboratory ﬁndings showed remarkable
hypoproteinemia and lymphopenia. Urgent diagnostic par-
acentesis showed the ascites to be a white milky ﬂuid con-
taining high levels of triglycerides (564 mg/dl), leading to a
diagnosis of chyloperitoneum. Daily nutrition of the patient
was entirely with a fat-free ED (30 kcal/kg/day of Elental
,
AjinomotoPharmaceuticalCo.Ltd,Tokyo,Japan).Afterthe
initiation of oral Elental
, abdominal distension, hypopro-
teinemia, and lymphopenia gradually improved. Abdominal
CT performed 7 weeks after surgery showed no ascitic ﬂuid
in the abdomen, and thereafter a normal diet was initiated.
Since then, no relapse of chyloperitoneum has been proven.
Asaresult,thechylousasciteswassuccessfullytreatedinthe
outpatient clinic.
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Introduction
Chylousascitesoccurringafterabdominalsurgeryisrarebut
has been reported in certain populations [1–4]. The reported
incidence of this condition has varied because it is rare and
sometimes asymptomatic [1–4]. If it becomes symptomatic,
however, a massive loss of fat/protein-enriched ﬂuid and
lymphocytes can cause severe malnutrition and susceptibil-
ity to infection, leading to fatality [1–7]. Because of its rare
occurrence, there is no consensus for management of this
potentiallylethalcomplication[1–7].Therefore,reportingof
new cases is useful for sharing valid experiences.
Sporadic case reports showed that total parenteral nutri-
tion (TPN) with or without octreotide (or somatostatin) was
effectiveforeradicatingthiscondition[3–7].However,TPN
management requires hospitalization and a central venous
catheter which is an invasive procedure [8]. Furthermore,
treatment with octreotide and/or somatostatin requires close
medical vigilance and high medical costs [8–11]. Here we
present a case of massive chylous ascites occurring after
rectal surgery which was successfully treated with an oral
fat-free elemental diet (ED) in the outpatient clinic.
Case report
A 67-year-old man underwent low anterior resection with
para-aortic lymphadenectomy for advanced rectal cancer.
Neither neoadjuvant radiotherapy nor chemotherapy was
G. Nakayama  D. Morioka (&)  T. Murakami 
H. Takakura  Y. Miura  S. Togo
Department of Surgery, Yokohama Ekisaikai Hospital,
1-2 Yamada-cho, Naka-ku, Yokohama 231-0036, Japan
e-mail: dmorioka@hotmail.com
123
Clin J Gastroenterol (2012) 5:216–219
DOI 10.1007/s12328-012-0304-7performed. Early postoperative course was uneventful and
the patient was discharged from hospital 10 days after the
surgery. After discharge, however, abdominal distension
developed and rapidly deteriorated. On the routine outpa-
tient visit planned 21 days after surgery, the patient suf-
fered from a severe sense of abdominal fullness and
remarkable abdominal distension was noted with 92 cm
of abdominal girth measured at the umbilicus. An emer-
gency abdominal computed tomography (CT) scan proved
that abdominal distension was caused by massive ascites
(Fig. 1). Urgent diagnostic paracentesis showed that the
ascites was a white milky ﬂuid containing high levels of
triglycerides (546 mg/dl), leading to a diagnosis of massive
chylous ascites. Simultaneous laboratory ﬁndings showed
severe hypoproteinemia (total protein 4.5 g/dl, albumin
2.1 g/dl) and lymphopenia (white cell count 3000/ll,
lymphocyte count 150/ll). However, neither abdominal
pain nor other signs suggestive of infection were found.
Based on sporadic evidence that TPN with or without
octreotide was reported to be effective for eradicating
chyloperitoneum occurring after abdominal surgery [1–7],
emergency admission was offered to the patient but
rejected due to social reasons. Therefore, an oral fat-free
ED (30 kcal/kg/day of Elental
, Ajinomoto Pharmaceuti-
cal Co. Ltd, Tokyo, Japan) was initiated. Elental
 was
given orally two or three times a day. Oral intake was
strictly restricted to Elental
, water, and sugar/milk-free
beverage. The patient was seen weekly in the outpatient
clinic. After the initiation of oral Elental
, abdominal
distension gradually improved. Most notably, the sense of
abdominal fullness dramatically abated a few days after
starting Elental
. His abdominal girth decreased to 82 cm
and an abdominal CT scan showed no ascitic ﬂuid in the
abdomen 42 days after surgery. At that time, hypopro-
teinemia and lymphopenia improved (total protein 7.2 g/dl,
albumin 4.2 g/dl, white cell count 6300/ll, lymphocyte
count 2010/ll). Accordingly, the ED was totally replaced
by a normal diet the following day, after which no
abdominal distension was noted. As a result, the chylous
ascites was successfully treated in the outpatient clinic. Six
months after rectal surgery, the patient underwent partial
hepatectomy (S8 segmentectomy) for liver metastasis
originating from the rectal cancer. At that time, no ascitic
ﬂuid was seen in the abdomen. The patient is doing well
without evidence of cancer recurrence or chyloperitoneum
at 18 months after the initial rectal surgery (Fig. 2).
Fig. 1 Abdominal computed tomography performed 3 weeks after
surgery. Massive ascites was seen in the abdomen
Fig. 2 Abdominal computed tomography performed 7 weeks after
the surgery. No ascitic ﬂuid was seen in the abdomen
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Chylous ascites is caused by the unrecognized disruption of
a major lymphatic channel during lymphadenectomy [1–7].
The most important issue regarding this rare but signiﬁcant
complication relates to prevention. Meticulous and sys-
tematic use of ligation or hemoclips before dividing dis-
tinguishable lymphatic vessels is essential for preventing
this condition, notably in areas such as the para-aortic
region where abdominal lymphatic systems converge and
lymphatic ﬁstula is apt to occur [1–7]. However, lymphatic
vessels are often indistinguishable and thus chylous ascites
cannot be completely prevented. Therefore, it is very
important to establish a treatment strategy for this
complication.
The choice of treatment for chylous ascites after
abdominal surgery ranges from surgery to conservative
treatment [1–7]. If the origin of the leak is deﬁnitely
detected then surgical repair is preferred [12, 13]. How-
ever, imaging modalities for lymphatic structure in the
abdomen require special instruments, materials, and
expertise and are often unreliable [1–7, 12, 13]. Even if
preoperative detection of the leakage site is available, the
success rate of surgical repair for chylous ascites or
abdominal lymphatic ﬁstula has been reported to be low at
approximately 50 % because the anatomy of lymphatic
systems in the abdomen is inconsistent unlike in the thorax
[1–7]. As an initial treatment, therefore, surgical repair is
considered to be impractical on many occasions.
As stated above, sporadic case reports showed that TPN
with or without octreotide (or somatostatin) is promising
for this complication [1–7]. However, these treatments
require invasive procedures [8], close medical vigilance,
and high medical costs [9–11]. In contrast, oral ED does
not require speciﬁc instruments or procedures and is
available in the outpatient clinic. Elental
, which was used
in this case, is almost the same formula as VIVONEX

T.E.N. (Nestle ´) which is available in many Western
countries [14]. Elental
 consists of 15 % protein, 83.5 %
carbohydrate, and 1.5 % fat (caloric distribution, % of
kcal) and can provide nearly fat-free enteral nutrition [15],
which does not need nutritional transport via mesenteric
lymphatic systems and is therefore reasonable for miti-
gating chylous ascites [1–7]. Furthermore, Elental
 is a
completely digested formula and easily absorbed without
digestive juice secretion, therefore, seldom causing bowel
peristalsis which activates intra-abdominal lymphatic ﬂow
[14–16]. From this aspect, Elental
 is considered superior
to a conventional low-fat diet or medium-chain fat diet
which requires digestive juice secretion for absorption and
causes bowel peristalsis [1–5, 14–16]. Therefore, Elental

is considered markedly beneﬁcial for decreasing intra-
abdominal lymphatic ﬂow and nutritionally promoting
wound healing to repair disrupted lymph vessels. It was
reported that conservative treatments for symptomatic
postoperative chylous ascites required long-term (report-
edly 40–90 days) management to achieve complete
recovery [1–7]. In our case, this was achieved 28 days after
initiating the Elental
 diet. Furthermore, the patient was
relieved from the severe sense of abdominal fullness
shortly after starting the diet. These ﬁndings suggest that
Elental
 may be promising for treating postoperative
chylous ascites. When prescribing an oral ED, low com-
pliance was a problem because of its tastelessness [16];
however, various ﬂavors have become available recently
and compliance was reported to have increased [16]. If oral
application is unendurable, feeding via enteral tube is
available and considered to be superior in intrinsic safety to
TPN. Thus, fat-free ED can be recommended as an initial
treatment for chylous ascites occurring after abdominal
surgery because it is easy to start, intrinsically safe, and can
be performed in the outpatient clinic if oral intake is
available. Lacking strong evidence of its effectiveness,
however, other treatment modalities such as TPN with or
without octreotide must be initiated when ED is ineffec-
tive. Furthermore, surgical repair must always be consid-
ered; cases have been reported where conservative
management did not cure chyloperitoneum and surgical
repair was necessary [1–7]. Hence, it should be emphasized
that meticulous, tactful, and appropriate management
according to the individual case is essential for this rare but
signiﬁcant complication.
In conclusion, an oral fat-free ED can be recommended
as an initial treatment for chylous ascites occurring after
abdominal surgery because it is easy to start, intrinsically
safe, and available in the outpatient clinic.
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